Invention Grant
- Patent Title: Nitrogen-containing heterocyclic compound
- Patent Title (中): 含氮杂环化合物
-
Application No.: US14693342Application Date: 2015-04-22
-
Publication No.: US09315458B2Publication Date: 2016-04-19
- Inventor: Masami Yamada , Shinkichi Suzuki , Takahiro Sugimoto , Minoru Nakamura , Hiroki Sakamoto , Makoto Kamata
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company, Limited
- Current Assignee: Takeda Pharmaceutical Company, Limited
- Current Assignee Address: JP Osaka
- Agency: Hamre, Schumann, Mueller & Larson, P.C.
- Priority: JP2014-089585 20140423
- Main IPC: C07D209/46
- IPC: C07D209/46 ; C07D403/10 ; C07D405/14 ; C07D403/04 ; C07D401/10 ; C07D401/14
Abstract:
The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like.The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.
Public/Granted literature
- US20150307451A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND Public/Granted day:2015-10-29
Information query
